Carbapenem-resistant bacteria in the environment
- PMID: 40561412
- PMCID: PMC12193995
- DOI: 10.2478/aiht-2025-76-3956
Carbapenem-resistant bacteria in the environment
Abstract
Carbapenem-resistant bacteria (CRB) pose a significant threat to public health due to their resistance to last-resort antibiotics. Even though they are widely studied in clinical settings, much less is known about their presence in environmental compartments with multiple pathways contributing to their dissemination, which raises a growing concern. The aim of this narrative review is to summarise the current knowledge about the occurrence, isolation, and characterisation of CRB in hospital and natural environments and to highlight their clinical relevance and environmental reservoirs. The CRB species pathogenic for humans - Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa - are often identified in hospital and urban sewage, wastewater treatment plants, water bodies, sediments, soil, animals, and plants. Their presence in these environments is largely attributed to anthropogenic factors such as the discharge of untreated or partially treated effluent from wastewater treatment plants. Suitable methods for CRB isolation include selective media, phenotypic assays, and molecular tools for species identification and resistance gene detection. This review also addresses the One Health approach, which stems from the interconnectedness of humans, animals, and environment in the spread of CRB. While the species-level transmission within the One Health framework is well-documented, further research is needed to establish strain-level dissemination patterns. Understanding the mechanisms of CRB persistence and transmission in diverse environments is crucial for developing effective mitigation strategies to curb their spread.
Bakterije otporne na antibiotike karbapeneme (engl. carbapenem-resistant bacteria, krat. CRB) ozbiljna su prijetnja javnom zdravlju zbog svoje otpornosti na antibiotike posljednje linije obrane. Iako ih se opsežno proučavalo u bolničkim okružjima, njihova prisutnost u okolišu postaje sve veći problem, pri čemu višestruki čimbenici doprinose njihovu širenju. Ovaj narativni pregledni rad istražuje prisutnost, izolaciju i karakterizaciju CRB-a u bolničkom okružju i okolišu, ističući njihovu kliničku relevantnost i prirodne rezervoare. Patogene vrste CRB-a, kao što su Acinetobacter baumannii, Klebsiella pneumoniae i Pseudomonas aeruginosa, učestalo se mogu naći u bolničkim i komunalnim otpadnim vodama, postrojenjima za pročišćavanje otpadnih voda, vodnim tijelima, sedimentima, tlu, životinjama i biljkama. Njihova prisutnost u prirodi uglavnom se pripisuje antropogenom utjecaju, kao što je ispuštanje nepročišćenih ili djelomično pročišćenih otpadnih voda. U radu se opisuje i metodologija za izolaciju CRB-a, uključujući upotrebu selektivnih hranjivih podloga, fenotipskih testova i molekularnih alata za identifikaciju vrsta te detekciju gena za rezistenciju. Nadalje, istražen je i koncept jednog zdravlja (One Health), naglašavajući međusobnu povezanost ljudi, životinja i okoliša u širenju bakterija otpornih na antibiotike. Iako je prijenos između različitih bakterijskih vrsta dobro proučen unutar ovoga koncepta, potrebna su daljnja istraživanja kako bi se utvrdili obrasci širenja na razini sojeva. Razumijevanje mehanizama opstanka i prijenosa CRB-a u različitim prirodnim staništima ključno je za razvoj učinkovitih strategija ublažavanja i suzbijanja njihova širenja.
Keywords: One Health approach; antibiotici; antibiotics; bolnički okoliš; hospital environment; koncept jednog zdravlja; natural environment; prirodni okoliš; resistance; rezistencija.
© 2025 Blanka Dadić et al., published by Sciendo.
Conflict of interest statement
None to declare.
Figures
References
-
- Xenex. CDC says post-antibiotic era is already here. 2024. [displayed 9 December 2024]. Available at https://xenex.com/cdc-says-post-antibiotic-era-is-already-here/
-
- World Health Organization. Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis. 2017. [displayed 24 April 2025]. Available at https://www.who.int/publications/i/item/WHO-EMP-IAU-2017.12 .
-
- World Health Organization. WHO bacterial priority pathogens list, 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. 2024. [displayed 24 April 2025]. Available at https://www.who.int/publications/i/item/9789240093461 . - PubMed
-
- European Centre for Disease Prevention and Control and World Health Organization. Antimicrobial resistance surveillance in Europe 2023 – 2021 data. Stockholm: Publications Office of the European Union; 2023. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
